focuses on a new study that suggests drug price increases are
engineered to cover the costs of Direct-to-Consumer Advertising (DTCA).
Drug price trend data from AARP, AHRQ, and prescription drug consumer
price index (CPI) are presented.
Topic headings include:
Read this article now. It's FREE...
- AARP Rx Watchdog Report
- Flaws in the AARP Report
- Engineered Drug Price Increase
- DTC Ad Spend Chart
- Industry Says No Direct Link to DTC
- Plavix and Medicaid
- Smoking Gun Charts
- Pharmacos Spend More on DTCA When There is No Competition
- Plausible or Dubious?
Download PDF file